Table 1.
Publication | Setting | Period | Age*, yr. (% male) | Admissions/referrals/visits | Miscellaneous | |
---|---|---|---|---|---|---|
Pre-COVID | COVID | |||||
Au, 2020 [20] Abstract |
Adelaide, Australia Single center |
Pre-COVID: Mar 20–May 30, 2019 COVID: Mar 20–May 30, 2020 |
Pre-COVID: 50 COVID: 47 |
AH admissions of EtOH-related admissions: 13/336 | AH admissions of EtOH-related admissions: 17/372 |
• 11% increase in EtOH-related admissions • 11% increase in AH admissions during COVID |
Bahar, 2021 [21] Abstract |
CA, USA Single center |
Pre-COVID: Jul 2007–Jan 2020 COVID: Feb 2020–Apr 2021 |
Pre-COVID: 47 (61) COVID: 47 (63) |
AH admissions: 411 | AH admissions: 83 |
• 1.34 additional monthly AH admission during COVID • AH admissions did not increase relatively to increasing overall admissions |
Cargill, 2021 [44] Letter |
London, UK Single center |
Pre-COVID: Jun 2019 COVID: Jun 2020 |
Pre-COVID: 49 (64) COVID: 50 (60) |
AH presentations of ArLD referrals: 11/28 (39%) | AH presentations of ArLD referrals: 26/67 (39%) | NR |
Chung, 2021 [23] Abstract |
MA, USA Single center |
Pre-COVID: Mar 23–Jul 19, 2019 COVID: Mar 23–Jul 19, 2020 |
NR | NR | NR |
• Consults for EtOH-related GI: 60% increase • Consults for AH: 127% increase during COVID |
Damjanovska, 2022 [36•] Full-text article |
USA Multi center (40 US health care systems) |
Pre-COVID: 1999–Jun 20, 2020 COVID: Jun 21, 2020–Jun 20, 2021 |
Pre-COVID: NR (67) COVID: NR (64) |
Prevalence AH per 100,000: 23,350 | Prevalence AH per 100,000: 8320 |
• AH OR 2.77 • AH women OR 1.14 • AH African Americans OR 2.63 |
Dhanda, 2020 [47] Poster |
UK Multi center (28 hospitals) |
Pre-COVID: Aug 2019 COVID: Aug 2020 |
Pre-COVID: 55 (63) COVID: 55 (63) |
ArLD admissions: 223 | ArLD admissions: 263 | 18% increase in ArLD admissions during COVID |
Grinspoon, 2021 [25] Abstract |
MA, USA Multi center |
Pre-COVID: Mar 10, 2016–Mar 9, 2020 COVID: Mar 10, 2020–Mar 9, 2021 |
NR | AH admissions/year: 27 | AH admissions/year: 49 | 81% increase in AH admissions for patients 40 years or younger during COVID |
Itoshima, 2021 [37] Full-text article |
Japan Multi center (257 hospitals) |
Pre-COVID: Jul 2018–Mar 2020 COVID: Apr–Jun 2020 |
NR | NR | NR |
• RR 1.21 increase in ArLD admissions during COVID • 14% of ArLD had AH |
Jain, 2021 [26] Abstract |
OH, USA Single center |
Pre-COVID: Mar 1–Aug 31, 2019 COVID: 2020 (during lockdown) |
NR | 86 | 162 | NR |
Moore, 2021 [27] Abstract |
NE, USA Single center |
Pre-COVID: 2016–2019 COVID: Q2–Q4 2020 |
Pre-COVID: 48 (59) COVID: 44 (62) |
Total AH hospitalizations: 162 SAH hospitalizations: 127 (78%) |
Total AH hospitalizations: 95 SAH hospitalizations: 78 (82%) |
NR |
Nair, 2021 [28] Abstract |
HCA Healthcare, USA Multi center (185 US hospitals) |
Pre-COVID: Feb 2019–Sept 2019 COVID: Feb 2020–Sept 2020 |
NR | AH + ALF-related admissions of all admissions: 6.5% | AH + ALF-related admissions of all admissions: 7.4% | 7% increase in cases among women during COVID |
Ngu, 2021 [29] Abstract |
Monash Health, Australia |
Pre-COVID: Jul 1–Oct 31, 2019 COVID: Jul 1–Oct 31, 2020 |
NR | AH admissions of ALD/pancreatitis admissions: 10/66 (15%) | AH admissions of ALD/pancreatitis admissions: 33/100 (33%) | 100% increase in AH admissions during COVID |
Perisetti, 2021 [45] Letter to editor |
50 healthcare organizations worldwide Multi center |
Pre-COVID: Jan 1–Dec 1, 2019 COVID: Jan 1–Dec 1, 2020 |
Pre-COVID: 50 (65) COVID: 50 (64) |
AH hospitalizations: 18,818 | AH hospitalizations: 4383 | NR |
Pradhan, 2021 [30] Abstract |
AZ, USA Multi center |
Pre-COVID: Mar 1–Dec 31, 2019 COVID: Mar 1-Dec 31, 2020 |
Pre-COVID: 42 (61) COVID: 40 (64) |
AH admissions in non-cirrhotic adults: 225 | AH admissions in non-cirrhotic adults: 296 | 32% increase in admissions during COVID |
Rutledge, 2021 [38] Full-text article |
New York City, USA Single center |
Pre-COVID: Jan 1–Mar 21, 2020 COVID: Mar 22–Aug 25, 2020 |
Pre-COVID: 49 (50) Post-COVID: 47 (63) |
AH admissions: 18 | AH admissions: 49 | NR |
Schimmel, 2021 [39] Full-text article |
New York City, USA Multi center (5 hospitals) |
Pre-COVID: Mar 1–May 31, 2019 COVID: Mar 1–May 31, 2020 |
Pre-COVID: 46 (77) COVID: 47 (79) |
AH visits of EtOH-related visits: 10/2790 (0.4%) | AH visits of EtOH-related visits: 7/1793 (0.4%) | NR |
Shaheen, 2021 [40] Full-text article |
Canada Multi center (3 databases) |
Pre-COVID: Mar 2018–Feb 2020 COVID: Mar–Sept 2020 |
Pre-COVID: 46 (62) COVID: 44 (66) |
AH admissions: 991 AH admissions per 10,000: 11.6 |
AH admissions: 417 AH admissions per 10,000: 22.1 |
• 9% monthly increase in AH hospitalization • Admitted patients for AH were younger, more likely from rural areas, lower HCV prevalence, lower comorbidity rates during COVID |
Silva, 2021 [31] Abstract |
Portugal Single center |
Pre-COVID: Mar 15, 2019–Mar 14, 2020 COVID: Mar 15, 2020–Mar 15, 2021 |
Pre-COVID: 63 (70) COVID: 63 (69) |
AH presentations in DLC presentation: 6% of 66 | AH presentations in DLC presentation: 14% of 74 | NR |
Smart, 2021 [32] Abstract |
Australia Single center |
NR | NR | NR | NR |
• 11% increase AH admissions • 48% increase in admission related to acute alcohol intoxication during COVID |
Sohal, 2021 [41] Full-text article |
CA, USA Multi center (3 community hospitals) |
Pre-COVID: Jan 1–Dec 15, 2019 COVID: Jan 1–Dec 15, 2020 |
Pre-COVID: 48 (82) COVID: 47 (73) |
AH admissions: 131 | AH admissions: 198 |
• 51% increase in hospitalizations • 69% increase in hospitalizations after stay-at-home orders • 94% increase in rehospitalizations • 50% increase in patients under < 40 • 125% increase in women during COVID |
Toy, 2021 [33] Abstract |
UT, USA Single center |
Pre-COVID: Q2 2019–Q1 2020 COVID: Q2 2020–Q1 2021 |
NR |
AH diagnoses per 1000 visits: 5.8 AH visits per 1000 visits: 4.2 |
AH diagnoses per 1000 visits: 7.5 AH visits per 1000 visits: 5.4 |
NR |
Wu, 2021 [34] Abstract |
MN, USA Single center |
Pre-COVID: Jan 1–Dec 31, 2019 COVID: Jan 1–Dec 31, 2020 |
Pre-COVID: 52 (62) COVID: 43 (52) |
AH admissions: 34 | AH admissions: 62 | 77% increase in annual AH admissions during COVID |
*Reported as mean or median; yr., years; COVID, coronavirus disease; AH, alcohol-associated hepatitis; EtOH, ethanol alcohol; ArLD, alcohol-related liver disease; NR, not reported; GI, gastrointestinal; US, United States; OR, odds ratio; Q, quarter; SAH, severe alcohol-associated hepatitis; ALF, acute liver failure; ALD, alcoholic liver disease; HCV, hepatitis C virus